US$ 28.38
glp 1 and glp 2 drugs GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness A Guide to Weight-Loss Medications:
Description
Search string: (Glucagon-Like Peptide-1 Receptor Agonist* OR GLP-1-RA* OR GLP-1-R* OR GLP-1 Receptor Agonist* OR Liraglutide OR Semaglutide OR Tirzepatide OR Exenatide OR Exendin-4) AND (Stem Cells[Mesh] OR stem cell* OR stromal cell* OR adult progenitor cell* OR hASC OR hASCs OR ASC OR ASCs OR adipose-derived stem cell* OR ADSC* OR MSC OR mesenchymal stem cell* OR mesenchymal stromal cell* OR mesenchymal progenitor cell* OR bone-marrow derived mesenchymal stem cell* OR BD-MSC* OR umbilical cord tissue derived mesenchymal stem cell* OR UC-MSC*) The date of the search was June 30th, 2025

191 The mechanism of GLP-1 RA to improve dopaminergic degeneration and pathological -synuclein aggregation in the PD model may involve inhibiting the PI3K/Akt/mTOR pathway 192 and enhancing AMPK/PGC-1a signaling pathway

Combined loss of GLP-1R and Y2R does not alter progression of high-fat diet-induced obesity or response to RYGB surgery in mice
10.1016/j.cmet.2013.04.008

Baseline age, sex, and demographic data were collected from the healthcare utilization database of the Korean NHIS

These are based largely on expert opinion and multi-society consensus, which may lead to variations in clinical practice both regionally and globally
